Roivant Sciences Ltd. (ROIV)

Roivant Sciences Revenue

Roivant Sciences had revenue of $9.02M in the quarter ending December 31, 2024, a decrease of -42.05%. This brings the company's revenue in the last twelve months to $122.59M, up 140.04% year-over-year. In the fiscal year ending March 31, 2024, Roivant Sciences had annual revenue of $124.80M with 103.65% growth.

• Revenue (ttm): $122.59M
• Revenue Growth: +140.04%
• P/S Ratio: 67.16
• Revenue / Employee: $135,006
• Employees: 908
• Market Cap: 7.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	124.80M	63.52M	103.65%
Mar 31, 2023	61.28M	5.99M	10.84%
Mar 31, 2022	55.29M	31.49M	132.34%
Mar 31, 2021	23.80M	-43.89M	-64.85%
Mar 31, 2020	67.69M	65.37M	2,812.61%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.